Extracellular vesicles of bacteria as potential targets for immune interventions

References

• Kegelman TP, Das SK, Emdad L, Hu B, Menezes ME, Bhoopathi P, Wang X-Y, Pellecchia M, Sarkar D, Fisher PB. Targeting tumor invasion: the roles of MDA-9/Syntenin. Expert Opin Ther Targets PMID:25219541. 2015;19(1):97–112. doi:10.1517/14728222.2014.959495.
   PubMed Web of Science ®Google Scholar
• van der Pol E, Boing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev PMID:22722893. 2012;64:676–705. doi:10.1124/pr.112.005983..
   PubMed Web of Science ®Google Scholar
• Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol PMID:19144520. 2009;19:43–51. doi:10.1016/j.tcb.2008.11.003.
   PubMed Web of Science ®Google Scholar
• Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol PMID:23420871. 2013;200:373–83. doi:10.1083/jcb.201211138..
   PubMed Web of Science ®Google Scholar
• Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic MM, Molina H, Kohsaka S, Di Giannatale A, Ceder S, et al. Tumour exosome integrins determine organotropic metastasis. Nature PMID:26524530. 2015;527:329–35. doi:10.1038/nature15756..
   PubMed Web of Science ®Google Scholar
• Wieckowski EU, Visus C, Szajnik M, Szczepanski MJ, Storkus WJ, Whiteside TL. Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J Immunol PMID:19692638. 2009;183:3720–30. doi:10.94049/jimmunol.0900970.
   PubMed Web of Science ®Google Scholar
• Yang L, Wu XH, Wang D, Luo CL, Chen LX. Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro. Mol Med Rep PMID:23969721. 2013;8:1272–78. doi:10.3892/mmr.2013.1634.
   PubMed Web of Science ®Google Scholar
• Lécrivain AL, Beckmann BM. Bacterial RNA in extracellular vesicles: A new regulator of host-pathogen interactions? Biochim Biophys Acta Gene Regul Mech PMID:32142907. 2020;1863:194–519. doi:10.1016/j.bbagrm.2020.194519.
   Web of Science ®Google Scholar
• Cai Q, He B, Weiberg A, Buck AH, Jin H. Small RNAs and extracellular vesicles: new mechanisms of cross-species communication and innovative tools for disease control. PLoS Pathog PMID:31887135. 2019;15:e1008090. doi:10.1371/journal.ppat.1008090.
   PubMed Web of Science ®Google Scholar
• Ma J, Zhao Y, Sun L, Sun X, Zhao X, Sun X, Qian H, Xu W, Zhu W. Exosomes Derived from Akt -Modified Human Umbilical Cord Mesenchymal Stem Cells Improve Cardiac Regeneration and Promote Angiogenesis via Activating Platelet-Derived Growth Factor D. Stem Cells Transl Med PMID:28170176. 2017;6(1):51–59. doi:10.5966/sctm.2016-0038.
   PubMed Web of Science ®Google Scholar
• Brown L, Wolf JM, Prados-Rosales R, Casadevall A. Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi. Nat Rev Microbiol PMID:26324094. 2015;13:620–30. doi:10.1038/nrmicro3480..
   PubMed Web of Science ®Google Scholar
• Kim JH, Lee J, Park J, Gho YS. Gram-negative and Gram-positive bacterial extracellular vesicles. Semin Cell Dev Biol PMID:25704309. 2015;40:97–104. doi:10.1016/j.semcdb.2015.02.006.
   PubMed Web of Science ®Google Scholar
• Simons M, Raposo G. Exosomes–vesicular carriers for intercellular communication. Curr Opin Cell Biol PMID:19442504. 2009;21:575–81. doi:10.1016/j.ceb.2009.03.007.
   PubMed Web of Science ®Google Scholar
• Tkach M, Théry C. Communication by Extracellular Vesicles: where We Are and Where We Need to Go. Cell PMID:26967288. 2016;164:1226–32. doi:10.1016/j.cell.2016.01.043..
   PubMed Web of Science ®Google Scholar
• Szatanek R, Baj-Krzyworzeka M, Zimoch J, Lekka M, Siedlar M, Baran J. The Methods of Choice for Extracellular Vesicles (EVs) Characterization. Int J Mol Sci. 2017. doi:18.doi:10.3390/ijms18061153. PMID:28555055.
   PubMedGoogle Scholar
• Piotrowska M, Ciura K, Zalewska M, Dawid M, Correia B, Sawicka P, Lewczuk B, Kasprzyk J, Sola L, Piekoszewski W, et al. Capillary zone electrophoresis of bacterial extracellular vesicles: A proof of concept. J Chromatogr A. 2020. PMID:32197757. doi:1621:461047.doi:10.1016/j.chroma.2020.461047
   PubMed Web of Science ®Google Scholar
• Gould SJ, Raposo G. As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles. 2013. doi:2.doi:10.3402/jev.v2i0.20389. PMID:24009890.
   PubMedGoogle Scholar
• Macia L, Nanan R, Hosseini-Beheshti E, Grau GE. Host- and Microbiota-Derived Extracellular Vesicles, Immune Function, and Disease Development. Int J Mol Sci. 2019. doi:21.doi:10.3390/ijms21010107. PMID:31877909.
   PubMed Web of Science ®Google Scholar
• Dagnelie MA, Corvec S, Khammari A, Dréno B. Bacterial extracellular vesicles: A new way to decipher host-microbiota communications in inflammatory dermatoses. Exp Dermatol PMID:31633842. 2020;29:22–28. doi:10.1111/exd.14050..
   PubMed Web of Science ®Google Scholar
• Roier S, Zingl FG, Cakar F, Schild S. Bacterial outer membrane vesicle biogenesis: a new mechanism and its implications. Microb Cell PMID:28357362. 2016;3:257–59. doi:10.15698/mic2016.06.508.
   PubMed Web of Science ®Google Scholar
• Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol PMID:12524386. 2003;21:335–76. doi:10.1146/annurev.immunol.21.120601.141126.
   PubMed Web of Science ®Google Scholar
• Kulkarni HM, Nagaraj R, Jagannadham MV. Protective role of E. coli outer membrane vesicles against antibiotics. Microbiol Res PMID:26640046. 2015;181:1–7. doi:10.1016/j.micres.2015.07.008.
   PubMed Web of Science ®Google Scholar
• Thay B, Damm A, Kufer TA, Wai SN, Oscarsson J. Aggregatibacter actinomycetemcomitans outer membrane vesicles are internalized in human host cells and trigger NOD1- and NOD2-dependent NF-kappaB activation. Infect Immun PMID:25024364. 2014;82:4034–46. doi:10.1128/IAI.01980-14.
   PubMed Web of Science ®Google Scholar
• Bitto NJ, Baker PJ, Dowling JK, Wray-McCann G, De Paoli A, Tran LS, Leung PL, Stacey KJ, Mansell A, Masters SL, et al. Membrane vesicles from Pseudomonas aeruginosa activate the noncanonical inflammasome through caspase-5 in human monocytes. Immunology and Cell Biology PMID:30003588. 2018;96:1120–30. doi:10.1111/imcb.12190.
   PubMed Web of Science ®Google Scholar
• Bartolini E, Ianni E, Frigimelica E, Petracca R, Galli G, Berlanda SF, Norais N, Laera D, Giusti F, Pierleoni A, et al. Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro. J Extracell Vesicles. 2013. PMID:24009891. doi:2.doi:10.3402/jev.v2i0.20181
   PubMedGoogle Scholar
• Gujrati V, Kim S, Kim S-H, Min JJ, Choy HE, Kim SC, Jon S. Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy. ACS Nano PMID:24410085. 2014;8:1525–37. doi:10.1021/nn405724x.
   PubMed Web of Science ®Google Scholar
• Bobat S, Flores-Langarica A, Hitchcock J, Marshall JL, Kingsley RA, Goodall M, Gil-Cruz C, Serre K, Leyton DL, Letran SE, et al. Soluble flagellin, FliC, induces an Ag-specific Th2 response, yet promotes T-bet-regulated Th1 clearance of Salmonella typhimurium infection. Eur J Immunol PMID:21469112. 2011;41:1606–18. doi:10.1002/eji.201041089.
   PubMed Web of Science ®Google Scholar
• Turner KL, Cahill BK, Dilello SK, Gutel D, Brunson DN, Alberti S, Ellis TN. Porin Loss Impacts the Host Inflammatory Response to Outer Membrane Vesicles of Klebsiella pneumoniae. Antimicrob Agents Chemother PMID:26666932. 2015;60:1360–69. doi:10.1128/AAC.01627-15.
   PubMedGoogle Scholar
• Ellis TN, Kuehn MJ. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev PMID:20197500. 2010;74:81–94. doi:10.1128/MMBR.00031-09.
   PubMed Web of Science ®Google Scholar
• Yang J, Kim EK, Park HJ, McDowell A, Kim YK. The impact of bacteria-derived ultrafine dust particles on pulmonary diseases. Exp Mol Med PMID:32203101. 2020;52:338–47. doi:10.1038/s12276-019-0367-3.
   PubMed Web of Science ®Google Scholar
• Kim YS, Lee WH, Choi EJ, Choi JP, Heo YJ, Gho YS, Jee YK, Oh YM, Kim YK. Extracellular vesicles derived from Gram-negative bacteria, such as Escherichia coli, induce emphysema mainly via IL-17A-mediated neutrophilic inflammation. J Immunol PMID:25716999. 2015;194:3361–68. doi:10.4049/jimmunol.1402268.
   PubMed Web of Science ®Google Scholar
• Park K-S, Lee J, Jang SC, Kim SR, Jang MH, Lötvall J, Kim Y-K, Gho YS. Pulmonary inflammation induced by bacteria-free outer membrane vesicles from Pseudomonas aeruginosa. American Journal of Respiratory Cell and Molecular Biology PMID:23713467. 2013;49:637–45. doi:10.1165/rcmb.2012-0370OC.
   PubMed Web of Science ®Google Scholar
• Nahui PRA, Vanpouille C, Laghi L, Parolin C, Melikov K, Backlund P, Vitali B, Margolis L. Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues. Nat Commun. 2019. doi:10:5656.doi:10.1038/s41467-019-13468-9. PMID:31827089.
   Web of Science ®Google Scholar
• Lee WH, Choi HI, Hong SW, Kim KS, Gho YS, Jeon SG. Vaccination with Klebsiella pneumoniae-derived extracellular vesicles protects against bacteria-induced lethality via both humoral and cellular immunity. Exp Mol Med PMID:26358222. 2015;47:e183. doi:10.1038/emm.2015.59.
   PubMed Web of Science ®Google Scholar
• Unal CM, Schaar V, Riesbeck K. Bacterial outer membrane vesicles in disease and preventive medicine. Seminars in Immunopathology PMID:21153593. 2011;33:395–408. doi:10.1007/s00281-010-0231-y.
   PubMed Web of Science ®Google Scholar
• Di Pasquale A, Bonanni P, Garçon N, Stanberry LR, El-Hodhod M, Tavares Da Silva F. Vaccine safety evaluation: practical aspects in assessing benefits and risks. Vaccine PMID:27836435. 2016;34:6672–80. doi:10.1016/j.vaccine.2016.10.039.
   PubMed Web of Science ®Google Scholar
• McConnell MJ, Rumbo C, Bou G, Pachón J. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii. Vaccine PMID:21679737. 2011;29:5705–10. doi:10.1016/j.vaccine.2011.06.001.
   PubMed Web of Science ®Google Scholar
• Nieves W, Petersen H, Judy BM, Blumentritt CA, Russell-Lodrigue K, Roy CJ, Torres AG, Morici LA. A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis. Clin Vaccine Immunol PMID:24671550. 2014;21:747–54. doi:10.1128/cvi.00119-14.
   PubMed Web of Science ®Google Scholar
• Mitra S, Chakrabarti MK, Koley H. Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis. Vaccine PMID:23684822. 2013;31:3163–73. doi:10.1016/j.vaccine.2013.05.001.
   PubMed Web of Science ®Google Scholar
• Hirahara K, Nakayama T. CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm. Int Immunol PMID:26874355. 2016;28:163–71. doi:10.1093/intimm/dxw006.
   PubMed Web of Science ®Google Scholar
• Yasuda K, Takeuchi Y, Hirota K. The pathogenicity of Th17 cells in autoimmune diseases. Semin Immunopathol PMID:30891627. 2019;41:283–97. doi:10.1007/s00281-019-00733-8.
   PubMed Web of Science ®Google Scholar
• Holt KE, Wertheim H, Zadoks RN, Baker S, Whitehouse CA, Dance D, Jenney A, Connor TR, Hsu LY, Severin J, et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci U S A PMID:26100894. 2015;112:E3574–3581. doi:10.1073/pnas.1501049112.
   PubMed Web of Science ®Google Scholar
• Camilo V, Sugiyama T, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2017;22(Suppl). doi:1.doi:10.1111/hel.12405. PMID:28891130.
   PubMed Web of Science ®Google Scholar
• Liu Q, Li X, Zhang Y, Song Z, Li R, Ruan H, Huang X. Orally-administered outer-membrane vesicles from Helicobacter pylori reduce H. pylori infection via Th2-biased immune responses in mice. Pathogens and Disease. 2019;77: PMID:31504509. doi:10.1093/femspd/ftz050.
   Web of Science ®Google Scholar
• Hegerle N, Guiso N. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines. Expert Rev Vaccines PMID:24953157. 2014;13:1135–46. doi:10.1586/14760584.2014.932254.
   PubMed Web of Science ®Google Scholar
• Zurita ME, Wilk MM, Carriquiriborde F, Bartel E, Moreno G, Misiak A, Mills KHG, Hozbor D. A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against, Including Pertactin Deficient Strains. Frontiers in Cellular and Infection Microbiology PMID:31106160. 2019;9:125. doi:10.3389/fcimb.2019.00125.
   PubMed Web of Science ®Google Scholar
• Gerver SM, Mihalkova M, Bion JF, Wilson APR, Chudasama D, Johnson AP, Hope R. Surveillance of Bloodstream Infections in Intensive Care Units in England, May 2016-April 2017: epidemiology and Ecology. J Hosp Infect. 2020. doi:10.1016/j.jhin.2020.05.010. PMID:32422311.
   PubMed Web of Science ®Google Scholar
• Lee E-Y, Choi D-Y, Kim D-K, Kim J-W, Park JO, Kim S, Kim S-H, Desiderio DM, Kim Y-K, Kim K-P, et al. Gram-positive bacteria produce membrane vesicles: proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles. Proteomics PMID:19834908. 2009;9:5425–36. doi:10.1002/pmic.200900338.
   PubMed Web of Science ®Google Scholar
• Choi SJ, Kim M-H, Jeon J, Kim OY, Choi Y, Seo J, Hong S-W, Lee W-H, Jeon SG, Gho YS, et al. Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity. PloS One PMID:26333035. 2015;10:e0136021. doi:10.1371/journal.pone.0136021.
   PubMed Web of Science ®Google Scholar
• Pastor Y, Camacho A, Gil AG, Ramos R, ALd C, Peñuelas I, Irache JM, Gamazo C. Effective protection of mice against Shigella flexneri with a new self-adjuvant multicomponent vaccine. Journal of Medical Microbiology PMID:28721849. 2017;66:946–58. doi:10.1099/jmm.0.000527.
   PubMed Web of Science ®Google Scholar
• Cho KS, Kang SA, Kim SD, Mun SJ, Yu HS, Roh HJ. Dendritic cells and M2 macrophage play an important role in suppression of Th2-mediated inflammation by adipose stem cells-derived extracellular vesicles. Stem Cell Res. 2019. doi:39:101500.doi:10.1016/j.scr.2019.101500. PMID:31344653.
   Web of Science ®Google Scholar
• Kim HY, Lim Y, An SJ, Choi BK. Characterization and immunostimulatory activity of extracellular vesicles from Filifactor alocis. Mol Oral Microbiol PMID:31675472. 2020;35:1–9. doi:10.1111/omi.12272.
   PubMed Web of Science ®Google Scholar
• Badmasti F, Ajdary S, Bouzari S, Fooladi AAI, Shahcheraghi F, Siadat SD. Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection. Molecular Immunology PMID:26277277. 2015;67:552–58. doi:10.1016/j.molimm.2015.07.031.
   PubMed Web of Science ®Google Scholar
• Huang W, Yao Y, Long Q, Yang X, Sun W, Liu C, Jin X, Li Y, Chu X, Chen B, et al. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models. PloS One. 2014;9. PMID:24956279. doi:e100727.doi:10.1371/journal.pone.0100727.
   Web of Science ®Google Scholar
• MacLennan CA, Riddle MS, Chen WH, Talaat KR, Jain V, Bourgeois AL, Frenck R, Kotloff K, Porter CK. Consensus Report on Shigella Controlled Human Infection Model: clinical Endpoints. Clin Infect Dis PMID:31816065. 2019;69:S591–s595. doi:10.1093/cid/ciz891.
   PubMed Web of Science ®Google Scholar
• Camacho AI, de Souza J, Sánchez-Gómez S, Pardo-Ros M, Irache JM, Gamazo C. Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice. Vaccine PMID:21911022. 2011;29:8222–29. doi:10.1016/j.vaccine.2011.08.121.
   PubMed Web of Science ®Google Scholar
• Chitneni P, Beksinska M, Dietrich JJ, Jaggernath M, Closson K, Smith P, Lewis DA, Matthews LT, Smit J, Ndung’u T, et al. Partner notification and treatment outcomes among South African adolescents and young adults diagnosed with a sexually transmitted infection via laboratory-based screening. Int J STD AIDS. 2020;956462420915395. PMID:32403988. doi:10.1177/0956462420915395
   Web of Science ®Google Scholar
• Liu Y, Hammer LA, Liu W, Hobbs MM, Zielke RA, Sikora AE, Jerse AE, Egilmez NK, Russell MW. Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model. Mucosal Immunology PMID:28272393. 2017;10:1594–608. doi:10.1038/mi.2017.11.
   PubMed Web of Science ®Google Scholar
• Choi C-W, Park EC, Yun SH, Lee S-Y, Kim SI, Kim G-H. Potential Usefulness of Extracellular Membrane Vesicles as Antibacterial Vaccines. Journal of Immunology Research PMID:28210633. 2017;2017:7931982. doi:10.1155/2017/7931982.
   PubMed Web of Science ®Google Scholar
• de Figueiredo P, Ficht TA, Rice-Ficht A, Rossetti CA, Adams LG. Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions. The American Journal of Pathology PMID:25892682. 2015;185:1505–17. doi:10.1016/j.ajpath.2015.03.003.
   PubMed Web of Science ®Google Scholar
• Bagheri Nejad R, Yahyaraeyat R, Es-Haghi A, Nayeri Fasaei B, Zahraei Salehi T. Induction of specific cell-mediated immune responses and protection in BALB/c mice by vaccination with outer membrane vesicles from a Brucella melitensis human isolate. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica PMID:31514254. 2019;127:797–804. doi:10.1111/apm.12997.
   PubMed Web of Science ®Google Scholar
• Vetter V, Denizer G, Friedland LR, Krishnan J, Shapiro M. Understanding modern-day vaccines: what you need to know. Ann Med PMID:29172780. 2018;50:110–20. doi:10.1080/07853890.2017.1407035.
   PubMed Web of Science ®Google Scholar
• Langereis JD, de Jonge MI. Unraveling Haemophilus influenzae virulence mechanisms enable discovery of new targets for antimicrobials and vaccines. Curr Opin Infect Dis PMID:32304471. 2020;33:231–37. doi:10.1097/qco.0000000000000645.
   PubMedGoogle Scholar
• Michel LV, Kaur R, Zavorin M, Pryharski K, Khan MN, LaClair C, O’Neil M, Xu Q, Pichichero ME. Intranasal coinfection model allows for assessment of protein vaccines against nontypeable Haemophilus influenzae in mice. J Med Microbiol PMID:30136923. 2018;67:1527–32. doi:10.1099/jmm.0.000827.
   PubMed Web of Science ®Google Scholar
• Behrouzi A, Bouzari S, Siadat SD, Oloomi M, Davari M, Mazaheri H. Evaluation of the immunogenic property of NT H. influenzae protein D with Neisseria meningitidis OMV in BALB/c. Journal of Infection in Developing Countries PMID:28036315. 2016;10:1345–51. doi:10.3855/jidc.7513.
   PubMed Web of Science ®Google Scholar
• Batista-Duharte A, Martínez DT, Carlos IZ. Efficacy and safety of immunological adjuvants. Where is the cut-off? Biomed Pharmacother PMID:29894962. 2018;105:616–24. doi:10.1016/j.biopha.2018.06.026.
   PubMed Web of Science ®Google Scholar
• Trainor EA, Nicholson TL, Merkel TJ. Bordetella pertussis transmission. Pathog Dis PMID:26374235. 2015;73:ftv068. doi:10.1093/femspd/ftv068.
   PubMed Web of Science ®Google Scholar
• Bottero D, Zurita ME, Gaillard ME, Carriquiriborde F, Martin Aispuro P, Elizagaray M, Bartel E, Castuma C, Hozbor D. Outer-Membrane-Vesicle-Associated O Antigen, a Crucial Component for Protecting Against Infection. Frontiers in Immunology PMID:30459769. 2018;9:2501. doi:10.3389/fimmu.2018.02501.
   PubMed Web of Science ®Google Scholar
• Ylinen E, Salmenlinna S, Halkilahti J, Jahnukainen T, Korhonen L, Virkkala T, Rimhanen-Finne R, Nuutinen M, Kataja J, Arikoski P, et al. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome. Pediatr Nephrol. 2020. PMID:32323005. doi:10.1007/s00467-020-04560-0
   Web of Science ®Google Scholar
• Fingermann M, Avila L, De Marco MB, Vázquez L, Di Biase DN, Müller AV, Lescano M, Dokmetjian JC, Fernández Castillo S, Pérez Quiñoy JL. OMV-based vaccine formulations against Shiga toxin producing Escherichia coli strains are both protective in mice and immunogenic in calves. Human Vaccines & Immunotherapeutics PMID:29923791. 2018;14:2208–13. doi:10.1080/21645515.2018.1490381.
   PubMed Web of Science ®Google Scholar
• Pulido MR, García-Quintanilla M, Pachón J, McConnell MJ. A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection. Vaccine PMID:31843268. 2020;38:719–24. doi:10.1016/j.vaccine.2019.11.043.
   PubMed Web of Science ®Google Scholar
• Ellis TN, Leiman SA, Kuehn MJ. Naturally produced outer membrane vesicles from Pseudomonas aeruginosa elicit a potent innate immune response via combined sensing of both lipopolysaccharide and protein components. Infect Immun PMID:20605984. 2010;78:3822–31. doi:10.1128/iai.00433-10.
   PubMed Web of Science ®Google Scholar
• van der Pol L, Stork M. van der Ley P. Outer membrane vesicles as platform vaccine technology. Biotechnol J PMID:26912077. 2015;10:1689–706. doi:10.1002/biot.201400395.
   PubMed Web of Science ®Google Scholar
• Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol PMID:20948547. 2010;10:787–96. doi:10.1038/nri2868.
   PubMed Web of Science ®Google Scholar